The Chancellor’s Spending Review: transforming the UK into a ‘scientific superpower’
On Wednesday 25 November, the UK’s Chancellor of the Exchequer Rishi Sunak travelled from Downing Street to the House of…
26 Nov 2020
The rise of gout: examining drug development for an age-old disease
Gout is often thought of as an ancient disease, confined to overfed royals from years gone by. One notable patient was King Henry VIII, the corpulent English monarch, who suffered…
26 Nov 2020
UK to experience a third wave of Covid after Christmas – leading macroeconomic influencers
The UK government’s decision to ease coronavirus restrictions over the festive period will lead to a third wave of infection, amounting to increased transmission, unnecessary deaths and overrun hospitals, say…
25 Nov 2020
BioMarin and Deep Genomics team up on AI rare disease drug discovery
US rare disease-focused biotech BioMarin has entered a preclinical collaboration with Toronto-based artificial intelligence (AI) company Deep Genomics to discover and develop oligonucleotide drug candidates for four undisclosed rare diseases…
25 Nov 2020
Covid deepens urban income and racial inequalities – leading macroeconomic influencers
Most cities in the US are left on their own to tackle the Covid-induced recession, with the only alternative to cut budgets. Economists believe that these cuts hit hardest on…
24 Nov 2020
Is quantum computing pharma’s next big disruptor?
The next cutting-edge innovation in computing and IT is venturing into the quantum realm. Quantum computers leverage the capabilities of quantum physics and mechanics to solve problems that classical computers…
24 Nov 2020
Tackling private debt for Covid-19 resilience – leading macroeconomic influencers
Macroeconomic influencers believe that the number of jobs lost during the Covid-19 pandemic, can be moderated by tackling the effect of the pandemic on private debt that has directly impacted…